GGrantIndex
← Leaderboards

Subhash C. Chauhan

Sanford Research/Usd

$7,948,055
Attributed
$8,723,314
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY201025
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,375,005 · 9

By mechanism

U54$8,439,257 · 2
R01$6,385,229 · 4
U01$1,480,519 · 1
R13$70,000 · 2

Top collaborators

Others in their field

Top investigators on “Molecular

Research focus

MolecularMalignant NeoplasmsInnovationMediatingDiagnosisBaseSignal PathwayIn VitroTumor ProgressionNeoplasm MetastasisOncogenicPathway InteractionsPharmaceutical PreparationsResponseMucinsOverexpressionCessation Of LifeEtiologyCancer Health DisparityNanoparticleRegulationClinically RelevantPancreatic NeoplasmAntineoplastic Agents

Grant awards (33)

Rio Grande Valley Cancer Health Disparity Research Center$3,712,690
U54 · FY2025 · MD · contact PI
Rio Grande Valley Cancer Health Disparity Research Center$378,555
U54 · FY2025 · MD · contact PI
Rio Grande Valley Cancer Health Disparity Research Center$3,939,001
U54 · FY2024 · MD · contact PI
Rio Grande Valley Cancer Health Disparity Research Center$409,011
U54 · FY2024 · MD · contact PI
International Conference on Cancer Health Disparities$25,000
R13 · FY2024 · CA · contact PI
International Conference on Cancer Health Disparities$25,000
R13 · FY2023 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$332,374
R01 · FY2021 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$323,315
R01 · FY2021 · CA · contact PI
MUC13 Mucin in Colerectal Cancer Health Disparity$339,949
R01 · FY2020 · CA · contact PI
International Conference on Cancer Health Disparities$20,000
R13 · FY2020 · CA · contact PI
MUC13 Mucin in Colerectal Cancer Health Disparity$329,750
R01 · FY2019 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$298,584
R01 · FY2019 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$196,478
R01 · FY2019 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$140,790
R01 · FY2019 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$38,684
R01 · FY2019 · CA · contact PI
MUC13 Mucin in Colorectal Cancer Health Disparity$349,014
R01 · FY2018 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$347,700
R01 · FY2018 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$347,700
R01 · FY2018 · CA · contact PI
MUC13 Mucin in Colorectal Cancer Health Disparity$351,510
R01 · FY2017 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$347,700
R01 · FY2017 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$347,700
R01 · FY2017 · CA · contact PI
MUC13 Mucin in Colorectal Cancer Health Disparity$359,410
R01 · FY2016 · CA · contact PI
Development of Targeted Nanotechnology Platform for Pancreatic Cancer$347,700
R01 · FY2016 · CA · contact PI
Targeted Nanotherapy for Pancreatic Cancer$347,700
R01 · FY2016 · CA · contact PI
Etiology of cervical cancer health disparity in American Indian women$246,715
U01 · FY2016 · CA · contact PI
Etiology of cervical cancer health disparity in American Indian women$311,327
U01 · FY2015 · CA · contact PI
Etiology of cervical cancer health disparity in American Indian women$301,986
U01 · FY2014 · CA · contact PI
Aspects of MUC13 Mucin in Cancer$295,230
R01 · FY2013 · CA · contact PI
Etiology of cervical cancer health disparity in American Indian women$292,641
U01 · FY2013 · CA · contact PI
Etiology of cervical cancer health disparity in American Indian women$327,850
U01 · FY2012 · CA · contact PI
Aspects of MUC13 Mucin in Cancer$307,413
R01 · FY2012 · CA · contact PI
Aspects of MUC13 Mucin in Cancer$306,622
R01 · FY2011 · CA · contact PI
Aspects of MUC13 Mucin in Cancer$329,906
R01 · FY2010 · CA · contact PI